Nasdaq(NDAQ)

Search documents
History Says the Nasdaq Will Soar: 1 Brilliant AI Stock to Buy Now, According to Wall Street
The Motley Fool· 2025-06-19 07:12
Earlier this year, the Nasdaq Composite (^IXIC 0.13%) dropped into market correction territory as investors reacted to the prospect of sweeping tariffs. However, the index has historically rebounded sharply following those incidences, producing an average 12-month return of 21% following corrections since 2010. More broadly, the Nasdaq Composite has returned 11% annually over the last four decades. That suggests the index is headed much higher in the future. Buying stock in The Trade Desk (TTD 1.45%) is a s ...
Republic Digital Acquisition Company Announces the Separate Trading of its Class A Ordinary Shares and Warrants, Commencing June 23, 2025
GlobeNewswire News Room· 2025-06-17 20:20
New York, NY, June 17, 2025 (GLOBE NEWSWIRE) -- Republic Digital Acquisition Company (Nasdaq: RDAGU) (the “Company”) announced today that, commencing June 23, 2025, holders of the units sold in the Company’s initial public offering may elect to separately trade the Company’s Class A ordinary shares and warrants included in the units. No fractional warrants will be issued upon separation of the units and only whole warrants will trade. The Class A ordinary shares and warrants that are separated will trade on ...
Nasdaq-traded Chinese herb company hits near $30 billion market value after speculative surge
CNBC· 2025-06-17 11:53
Regencell CEO Yat-Gai Au controls 86.24% of the total number of shares outstanding, according to FactSet data.The company's year to date performance is off the charts too, having risen 46,000% in 2025. By Monday's close, Regencell, founded in 2014 and traded on Nasdaq under the ticker 'RGC' since 2021, had a total market capitalization of $29.7 billion, according to S&P Capital IQ.Shares of Regencell, which says it develops traditional Chinese herb treatments to treat childhood attention deficit hyperactivi ...
Take-Two Stock Is Crushing the Nasdaq in 2025. Is It a Buy?
The Motley Fool· 2025-06-17 00:45
Core Viewpoint - Take-Two Interactive has shown strong stock performance, up 27% year to date, significantly outperforming the Nasdaq Composite, which is up only 0.59% [1] - The company reported impressive financial results for fiscal 2025, with a focus on upcoming game releases, including GTA VI, to drive future growth [1][4] Recent Business Performance and Outlook - Take-Two's non-GAAP revenue grew 6% year over year in fiscal 2025, with a notable 17% increase in the most recent quarter [4] - Recurrent consumer spending, which includes player spending on virtual currency and content, accounted for 80% of bookings in fiscal 2025 [5] - For fiscal 2026, management projects bookings to increase by 6% to approximately $6 billion [6] - The highly anticipated GTA VI is set to release on May 26, 2026, with Wall Street estimating bookings could reach $9 billion in fiscal 2027 [7] Historical Growth and Future Projections - Over the past decade, Take-Two has achieved an annualized revenue growth rate of 18%, despite recent profit and cash flow impacts from the acquisition of Zynga [9] - The company aims to expand its game portfolio and increase recurrent consumer spending to enhance margins and revenue [10] - Management expressed confidence in achieving operating margins in the low to mid-20% range, similar to levels during the pandemic [11] Valuation and Investment Considerations - The stock is currently trading at high price-to-sales and forward price-to-earnings multiples, reflecting market expectations for growth [13] - A discounted cash flow model suggests an intrinsic value of $236, assuming double-digit revenue growth to $18 billion by 2035 with a 25% operating margin [15] - To justify a fair value of $300, more aggressive growth projections would be necessary, such as achieving a 30% operating margin or growing revenue to $25 billion [16] - While the stock has potential for modest returns, current valuations suggest it may not significantly outperform the broader market [17]
Nasdaq Announces Results from 2025 Annual Meeting of Shareholders
Globenewswire· 2025-06-16 20:30
All 12 Nominated Directors Elected Nasdaq Board Re-elects Adena T. Friedman as Chair of the Board NEW YORK, June 16, 2025 (GLOBE NEWSWIRE) -- Nasdaq, Inc. (Nasdaq: NDAQ) shareholders elected all nominated directors at the company’s Annual Meeting of Shareholders on Wednesday, June 11, 2025. All directors will serve one-year terms. The elected board members are: Melissa M. Arnoldi, EVP and General Manager for Business Solutions, AT&T Inc.Charlene T. Begley, Retired SVP and CIO, General Electric CompanyAdena ...
21Shares Expands Nasdaq Stockholm Offering with Five New Crypto ETP Listings
GlobeNewswire News Room· 2025-06-16 07:00
Core Viewpoint - The expansion of 21Shares AG's cryptocurrency exchange-traded products (ETPs) on Nasdaq Stockholm indicates a growing demand for regulated crypto investment products in the Nordic region [1][3]. Group 1: New Listings and Product Offerings - 21Shares has cross-listed five additional ETPs on Nasdaq Stockholm, increasing its total offerings to 10 ETPs in the region [1][4]. - The newly listed products include 21Shares Uniswap ETP (AUNI), 21Shares Avalanche ETP (AVAX), 21Shares Bitcoin Gold ETP (BOLD), 21Shares Solana Core Staking ETP (CSOL), and 21Shares Ethereum Core ETP (ETHC) [2][7]. Group 2: Market Demand and Investor Empowerment - The expansion reflects increasing demand from both retail and institutional investors for diversified and cost-effective crypto exposure [3]. - By offering a broader selection of single-asset and thematic crypto ETPs, 21Shares aims to empower investors to build customized and resilient portfolios [3]. Group 3: Product Features and Cost Efficiency - All ETPs are fully collateralized and traded in a regulated, liquid format, providing an easy gateway to digital assets without the need for direct wallet management [4]. - The annual fees for these products range from 0.21% to 2.50%, making them some of the most cost-efficient options in the market [4]. Group 4: Company Background and Market Position - 21Shares is recognized as the largest and most diversified crypto ETP provider in Europe, with listings across major exchanges including Euronext Paris, Euronext Amsterdam, London Stock Exchange, and SIX Swiss Exchange [5]. - The company was founded to enhance accessibility to cryptocurrency for investors and bridge the gap between traditional finance and decentralized finance [6].
QQDN: Brand New, For Trading, Not Holding, Nasdaq
Seeking Alpha· 2025-06-14 09:17
Group 1 - Understanding the use of tools, such as hammers and omelette pans, is essential before attempting to utilize them effectively [1] - Tim Worstall is recognized as a wholesaler of rare earth metals and an expert in scandium, contributing to various media outlets [1] Group 2 - The article does not provide specific investment recommendations or advice regarding the suitability of investments for particular investors [2] - Seeking Alpha emphasizes that past performance does not guarantee future results, highlighting the importance of independent analysis [2]
S&P 500 and Nasdaq: Tech Stocks Drop—Nvidia, Apple Down; Oil Powers Exxon Higher
FX Empire· 2025-06-13 17:05
EnglishItalianoEspañolPortuguêsDeutschالعربيةFrançaisImportant DisclaimersThe content provided on the website includes general news and publications, our personal analysis and opinions, and contents provided by third parties, which are intended for educational and research purposes only. It does not constitute, and should not be read as, any recommendation or advice to take any action whatsoever, including to make any investment or buy any product. When making any financial decision, you should perform your ...
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: CureVac N.V. (Nasdaq - CVAC), Know Labs, Inc. (NYSE American - KNW), Volato Group, Inc. (NYSE American - SOAR), Heliogen, Inc. (OTC - HLGN)
GlobeNewswire News Room· 2025-06-13 15:37
Group 1: CureVac N.V. Acquisition - CureVac will be acquired by BioNTech SE, with each CureVac share exchanged for approximately $5.46 in BioNTech ADSs, leading to an implied aggregate equity value of about $1.25 billion [2] - Upon completion of the transaction, CureVac shareholders are expected to own between 4% and 6% of BioNTech [2] - The investigation focuses on whether the CureVac Board breached its fiduciary duties by failing to conduct a fair process and whether the consideration provides fair value to shareholders [2] Group 2: Know Labs, Inc. Acquisition - Know Labs will be acquired by Goldeneye 1995 LLC, with the purchase price determined by dividing the sum of 1,000 Bitcoin and a cash amount for debt retirement and working capital by the per share price of $0.335 [4] - The investigation examines whether the Know Labs Board breached its fiduciary duties by not conducting a fair process and whether the deal offers fair value to shareholders [4] Group 3: Volato Group, Inc. Merger - Volato Group will merge with M2i Global, with M2i Global expected to own approximately 90% of the total shares of Volato post-merger [6] - The investigation is centered on whether the Volato Group Board breached its fiduciary duties by failing to conduct a fair process and the potential dilution of shareholders in the combined company [6] Group 4: Heliogen, Inc. Acquisition - Heliogen will be acquired by Zeo Energy Corp, with securityholders receiving shares valued at approximately $10 million based on a price of $1.5859 per share, subject to adjustments based on net cash at closing [8] - The investigation looks into whether the Heliogen Board breached its fiduciary duties by not conducting a fair process and whether the consideration provides fair value to shareholders [8]
Nasdaq 100 and S&P500: Oil News Lifts Energy, Defense Shares, Drags Down Travel and Tech Stocks
FX Empire· 2025-06-13 13:03
EnglishItalianoEspañolPortuguêsDeutschالعربيةFrançaisImportant DisclaimersThe content provided on the website includes general news and publications, our personal analysis and opinions, and contents provided by third parties, which are intended for educational and research purposes only. It does not constitute, and should not be read as, any recommendation or advice to take any action whatsoever, including to make any investment or buy any product. When making any financial decision, you should perform your ...